| Literature DB >> 30500301 |
João Paulo F Longo1, Carolina M Lucci2, Luís A Muehlmann3, Ricardo B Azevedo1.
Abstract
Entities:
Keywords: Doxil; EPR effect; Kaposi sarcoma; cancer; clinical trials; controlled drug release; dermatology; liposomes; nanomedicine; nanoparticles; oncology
Mesh:
Substances:
Year: 2018 PMID: 30500301 DOI: 10.2217/nnm-2018-0374
Source DB: PubMed Journal: Nanomedicine (Lond) ISSN: 1743-5889 Impact factor: 5.307